On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Geyser Brands Inc. (TSX.V: GYSR) Delivers Established Cannabis Labels to Consumer Health Care Markets

  • Geyser Brands recently received a processing license and implemented manufacturing at a licensed production (LP) facility
  • The company developed NanoFusion, an advanced nanotechnology drug-delivery system
  • GYSR recently acquired Solace Management Group Inc.

Now that cannabis is losing its illegitimacy, derivatives of the plant are permeating consumer markets at a rapidly growing pace, thanks to companies such as Geyser Brands Inc. (TSX.V: GYSR). The global cannabis-powered and science-led consumer health care company offers products in a diverse range of markets, from fast-moving consumer goods and over-the-counter pharmaceuticals to medical cannabis.

In October 2018, Geyser received its Health Canada cultivation license and, in June 2019, less than a year later, a standard processing license. Licenses for R&D and sales are pending. In addition, the company recently closed an acquisition that considerably increased its brand portfolio. Driven by a management team experienced in manufacturing and marketing, Geyser looks set to realize its vision of being a global player in the billion-dollar cannabis and plant-powered health care markets.

Given the company’s extensive brand portfolio, the world is Geyser’s oyster. GYSR has products in a number of global markets, including the trillion-dollar personal and skin-care market; the $575 billion personalized and complementary medicine market; the ballooning (CAGR 34.6 percent) legal-marijuana market, which has been forecasted to reach $146 billion by 2025; the $4.2 trillion wellness market; and the pet care market, which is worth around $132 billion.

Geyser recently closed on its acquisition of established hemp-brands manufacturer Solace Management Group Inc., which added two dozen wellness products and 57 SKUs to GYSR’s product lineup. The acquisition also comes with a 7,500-square-foot, GMP-compliant facility belonging to an existing innovation-hub and manufacturing subsidiary in Coquitlam, British Columbia (http://cnw.fm/SL9sV).

Solace also owns a number of brands with leading market positions in Canada, including Apawthecary Pets, WildTails pet products, Apothecary Naturals and Apothecary Ink, all of which currently use hemp oil in their formulations. The brands are distributed by leading retailers across Canada including Bosley’s and Shoppers Drug Mart. In addition, Solace recently received approval for sales of a new pain-relief, roll-on product thanks to a natural product number issued by Health Canada (http://cnw.fm/rjo8N).

And that’s not the only good news for Geyser. In June 2019, Apothecary Botanicals, Geyser’s wholly owned licensed producer (LP), received a standard processing license from Health Canada, a key development that allows the production of a variety of products including tinctures and supplements (http://cnw.fm/bEkP6).

In addition, Geyser has developed NanoFusion, an advanced nanotechnology drug-delivery system that transports therapeutic agents rapidly and efficiently directly to the bloodstream for maximum absorbency. In the past, a major challenge in producing cannabinoids for ingestion or absorption through the skin is their insolubility.

Cannabinoids are naturally hydrophobic (afraid of water), which makes it harder for the body to absorb them. The result is inconsistent, unreliable dosing and onset times of up to three hours. Geyser’s NanoFusion breaks down cannabinoid particles and combines them with naturally occurring surfactants that lower the surface tension between cannabinoids and water, resulting in a compound that is water compatible.

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/GYSR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office


Select A Month

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash





USD Coin

USD Coin

Contact us: 303.498.7722